{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:07:58Z","timestamp":1762340878866},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","obstetanesthesia.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Obstetric Anesthesia"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ijoa.2015.11.009","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T23:01:56Z","timestamp":1450220516000},"page":"79-82","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Heparin-induced thrombocytopenia in pregnancy: an interdisciplinary challenge\u2014a case report and literature review"],"prefix":"10.1016","volume":"26","author":[{"given":"E.","family":"Mauermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"V\u00f6kt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Tsakiris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Tobler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Girard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijoa.2015.11.009_b0005","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.ijoa.2015.11.009_b0010","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMct1206642","article-title":"Nonheparin anticoagulants for heparin-induced thrombocytopenia","volume":"368","author":"Kelton","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijoa.2015.11.009_b0015","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ijoa.2015.11.009_b0020","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1182\/asheducation-2003.1.497","article-title":"Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome","author":"Warkentin","year":"2003","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ijoa.2015.11.009_b0025","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood-2012-07-443051","article-title":"Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"120","author":"Cuker","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ijoa.2015.11.009_b0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1411910","article-title":"Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijoa.2015.11.009_b0035","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1111\/j.1538-7836.2011.04536.x","article-title":"Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis","volume":"9","author":"Warkentin","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ijoa.2015.11.009_b0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1160\/TH14-11-0974","article-title":"Scoring systems for heparin-induced thrombocytopenia (HIT): whither now?","volume":"113","author":"Warkentin","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijoa.2015.11.009_b0045","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/ajh.21032","article-title":"What is the potential for overdiagnosis of heparin-induced thrombocytopenia?","volume":"82","author":"Lo","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ijoa.2015.11.009_b0050","first-page":"g7566","article-title":"Heparin induced thrombocytopenia","volume":"350","author":"Linkins","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ijoa.2015.11.009_b0055","first-page":"148","article-title":"Laboratory diagnosis of immune heparin-induced thrombocytopenia","volume":"2","author":"Warkentin","year":"2003","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.ijoa.2015.11.009_b0060","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1111\/j.1538-7836.2010.04059.x","article-title":"The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion","volume":"8","author":"Cuker","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ijoa.2015.11.009_b0065","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1160\/TH14-05-0472","article-title":"External validation of the HIT Expert Probability (HEP) score","volume":"113","author":"Joseph","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijoa.2015.11.009_b0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2004-831039","article-title":"An overview of the heparin-induced thrombocytopenia syndrome","volume":"30","author":"Warkentin","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ijoa.2015.11.009_b0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/cc9993","article-title":"Heparin-induced thrombocytopenia in the ICU: an overview","volume":"15","author":"Sakr","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.ijoa.2015.11.009_b0080","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","volume":"96","author":"Warkentin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ijoa.2015.11.009_b0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1378\/chest.14-1417","article-title":"The role for optical density in heparin-induced thrombocytopenia: a cohort study","volume":"148","author":"Chan","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.ijoa.2015.11.009_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1378\/chest.15-0737","article-title":"There is no such thing as a \u201cpositive\u201d antibody test: diagnosing heparin-induced thrombocytopenia in 2015","volume":"148","author":"Rice","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.ijoa.2015.11.009_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1614206","article-title":"Heparin-induced thrombocytopenia: towards consensus","volume":"79","author":"Warkentin","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijoa.2015.11.009_b0100","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.114.003902","article-title":"Cardiovascular management in pregnancy: antithrombotic agents and antiplatelet agents","volume":"132","author":"Yarrington","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijoa.2015.11.009_b0105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ijoa.2015.11.009_b0110","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1067\/mob.2001.114690","article-title":"Heparin-induced thrombocytopenia is rare in pregnancy","volume":"185","author":"Fausett","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2015.11.009_b0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.thromres.2014.03.029","article-title":"Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)\u2013findings from the GerHIT multi-centre registry study","volume":"134","author":"Schindewolf","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.ijoa.2015.11.009_b0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.thromres.2014.03.045","article-title":"Voting with your fondaparinux","volume":"134","author":"Warkentin","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.ijoa.2015.11.009_b0125","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2014-09-599498","article-title":"Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study","volume":"125","author":"Kang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ijoa.2015.11.009_b0130","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.thromres.2015.04.001","article-title":"Fondaparinux in pregnancy: could it be a safe option? A review of the literature","volume":"135","author":"De Carolis","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.ijoa.2015.11.009_b0135","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/bjh.13147","article-title":"The use of fondaparinux in pregnancy","volume":"168","author":"Elsaigh","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijoa.2015.11.009_b0140","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1538-7836.2010.03926.x","article-title":"Fondaparinux as an alternative anticoagulant therapy during pregnancy","volume":"8","author":"Knol","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ijoa.2015.11.009_b0145","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.thromres.2011.10.037","article-title":"Fondaparinux \u2013 data on efficacy and safety in special situations","volume":"129","author":"Nagler","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.ijoa.2015.11.009_b0150","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/AOG.0b013e3182310c4c","article-title":"Practice bulletin no. 123: thromboembolism in pregnancy","volume":"118","author":"James","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2015.11.009_b0155","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bjh.12059","article-title":"Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition","volume":"159","author":"Watson","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijoa.2015.11.009_b0160","unstructured":"Association of the Scientific Medical Societies in Germany. German guidelines for thrombosis therapy. 2015. Available at: http:\/\/www.awmf.org\/leitlinien\/detail\/ll\/065-002.html. [accessed October 2015]."},{"key":"10.1016\/j.ijoa.2015.11.009_b0165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00115550-200311000-00022","article-title":"The use of concomitant antiplatelet drugs during neuraxial anesthesia is contraindicated in Germany","volume":"28","author":"Gogarten","year":"2003","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.ijoa.2015.11.009_b0170","unstructured":"Spahn DR, Borgeat A, Ravussin P, Kern C, Korte W, Swiss Society of Anesthesia and Resuscitation. Anwendung von Fondaparinux: Neue Guidelines f\u00fcr die An\u00e4sthesiologie 2009. http:\/\/www.sgar-ssar.ch\/fileadmin\/user_upload\/Dokumente\/Infos_zu_Medis\/An\u00e4sthesierichtlinien_Fondaparinux_Version_5_d.pdf. [accessed on October 2015]."},{"key":"10.1016\/j.ijoa.2015.11.009_b0175","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/EJA.0b013e32833f6f6f","article-title":"Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology","volume":"27","author":"Gogarten","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.ijoa.2015.11.009_b0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0049-3848(93)90178-Q","article-title":"Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172)","volume":"71","author":"Greinacher","year":"1993","journal-title":"Thromb Res"},{"key":"10.1016\/j.ijoa.2015.11.009_b0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1160\/TH04-06-0345","article-title":"Treatment of 51 pregnancies with danaparoid because of heparin intolerance","volume":"93","author":"Lindhoff-Last","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijoa.2015.11.009_b0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.thromres.2009.06.006","article-title":"An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran)","volume":"125","author":"Magnani","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.ijoa.2015.11.009_b0195","first-page":"89","article-title":"Danaparoid in pregnancy in cases of heparin intolerance \u2013 use in 59 cases","volume":"27","author":"Schindewolf","year":"2007","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.ijoa.2015.11.009_b0200","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1055\/s-0037-1613092","article-title":"Absence of placental transfer of pentasaccharide (Fondaparinux, Arixtra) in the dually perfused human cotyledon in vitro","volume":"87","author":"Lagrange","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijoa.2015.11.009_b0205","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1056\/NEJM200404293501825","article-title":"Minor transplacental passage of fondaparinux in vivo","volume":"350","author":"Dempfle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijoa.2015.11.009_b0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0897.2009.00733.x","article-title":"A retrospective analysis of fondaparinux versus enoxaparin treatment in women with infertility or pregnancy loss","volume":"62","author":"Winger","year":"2009","journal-title":"Am J Reprod Immunol"}],"container-title":["International Journal of Obstetric Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959289X15001600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959289X15001600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T02:53:21Z","timestamp":1718247201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959289X15001600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":42,"alternative-id":["S0959289X15001600"],"URL":"https:\/\/doi.org\/10.1016\/j.ijoa.2015.11.009","relation":{},"ISSN":["0959-289X"],"issn-type":[{"value":"0959-289X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin-induced thrombocytopenia in pregnancy: an interdisciplinary challenge\u2014a case report and literature review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Obstetric Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijoa.2015.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}